SCHEMBL5327734

SCHEMBL5327734

CC(C)(C)OC(=O)NCCCCC(N)C(=O)Nc1cccc2cccnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NLN Q9BYT8 1/20 0.49
HDAC4 P56524 6/20 0.48
MEF2D Q14814 2/20 0.48
EP300 Q09472 1/20 0.48
ANPEP P15144 1/20 0.47
HDAC1 Q13547 7/20 0.46
HDAC6 Q9UBN7 5/20 0.46
HDAC3 O15379 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
POLB P06746 1/20 0.46
CA1 P00915 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5327739 1.00 KDM4E (0.50) KDM4EL3MBTL1NLNHDAC4MEF2D
SCHEMBL8103276 0.87 HDAC6 (0.48) KDM4EL3MBTL1NLNHDAC4MEF2D
SCHEMBL8106567 0.87 HDAC6 (0.48) KDM4EL3MBTL1NLNHDAC4MEF2D
SCHEMBL5330916 0.86 HDAC4 (0.54) KDM4EL3MBTL1HDAC4MEF2DEP300
SCHEMBL5330900 0.86 HDAC4 (0.54) KDM4EL3MBTL1HDAC4MEF2DEP300
SCHEMBL5330903 0.85 KDM4E (0.45) KDM4EL3MBTL1NLNHDAC4MEF2D
SCHEMBL7762702 0.84 ALDH1A1 (0.49) KDM4EL3MBTL1ANPEPCA1CA2
SCHEMBL5326792 0.81 HDAC1 (0.71) HDAC4MEF2DEP300HDAC1HDAC6
SCHEMBL5326785 0.81 HDAC1 (0.71) HDAC4MEF2DEP300HDAC1HDAC6
SCHEMBL8252976 0.80 HDAC4 (0.58) KDM4EHDAC4MEF2DEP300HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 KDM4E 215/4885L3MBTL1 1644/4885NLN 4696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.